Phase I Study with a Weekly 1 h Infusion of Paclitaxel in Heavily Pretreated Patients with Metastatic Breast and Ovarian Cancer

By Klaassen U.   Wilke H.   Strumberg D.   Eberhardt W.   Korn M.   Seeber S.  

European Journal of Cancer, Vol. 32, Iss. 3, 1996-03 ,pp. : 547-549

Elsevier

Access to resources Recommend Favorite

A Phase II and Pharmacokinetic Study of Weekly 72-h Topotecan Infusion in Patients with Platinum-Resistant and Paclitaxel-Resistant Ovarian Carcinoma

By Rose P.G.   Gordon N.H.   Fusco N.   Fluellen L.   Rodriguez M.   Ingalls S.T.   Hoppel C.L.  

Gynecologic Oncology, Vol. 78, Iss. 2, 2000-08 ,pp. : 228-234

Elsevier

Access to resources Recommend Favorite

A Phase I Study of Weekly Topotecan and Paclitaxel in Previously Treated Epithelial Ovarian Carcinoma Patients

By Homesley H.   Benigno B.   Williams J.   Vaccarello L.  

Gynecologic Oncology, Vol. 87, Iss. 2, 2002-11 ,pp. : 171-177

Academic Press

Access to resources Recommend Favorite

Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinoma

By Ueno Hideki   Okada Shuichi   Okusaka Takuji   Ikeda Masafumi   Kuriyama Hitoshi  

Cancer Chemotherapy and Pharmacology, Vol. 49, Iss. 2, 2002-02 ,pp. : 155-160

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancer

By Polee M.B.   Verweij J.   Siersema P.D.   Tilanus H.W.   Splinter T.A.W.   Stoter G.   Van der Gaast A.  

European Journal of Cancer, Vol. 38, Iss. 11, 2002-07 ,pp. : 1495-1500

Elsevier

Access to resources Recommend Favorite